文献速递贫血与红细胞疾病

镰状细胞贫血患儿心脏异常纵向分析及羟基脲疗效

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy.
PubMed 文献 · Blood Adv · 2021-01-01

该回顾性研究分析了100例镰状细胞贫血患者(60%接受羟基脲治疗)的心脏超声异常患病率,并纵向评估羟基脲对心脏逆转重构的影响。发现羟基脲治疗不足1年者左室扩大患病率显著高于治疗超过1年者,且左室扩大和肥厚随治疗时间延长显著改善,左室容积和质量与治疗时长负相关。

要点

  • 羟基脲治疗不足1年者左室扩大患病率显著高于治疗超过1年者。
  • 羟基脲治疗可显著改善左室扩大和左室肥厚。
  • 左室容积和质量与羟基脲治疗时长呈负相关。

核心结论

  • 长期羟基脲治疗可能促进镰状细胞贫血患者心脏逆转重构。

研究设计与样本

  • 回顾性研究,纳入2010至2017年在Cohen儿童医学中心接受常规心脏筛查的镰状细胞贫血患者共100例,其中60例接受羟基脲治疗。

主要发现

  • 100例患者中60例(60%)接受羟基脲治疗。
  • 羟基脲治疗可显著改善左室扩大和左室肥厚。
  • 左室容积和质量与羟基脲治疗时长呈负相关。

临床怎么用

  • 对镰状细胞贫血患儿应常规进行心脏超声筛查。
  • 羟基脲治疗可能逆转心脏重构,支持长期坚持治疗。

局限性

  • 回顾性研究设计。
  • 未来需对该队列进行更长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiac abnormalities such as left ventricular hypertrophy, left ventricular dilation, and pulmonary hypertension in sickle cell anemia have been previously described. Hydroxyurea, a disease-modifying therapy for sickle cell anemia, has been used for several decades. Longitudinal assessment of echocardiographic abnormalities in children and young adults with sickle cell anemia receiving hydroxyurea therapy is lacking. The goal of this retrospective study was to determine the prevalence of echocardiographic abnormalities in children and young adults with sickle cell anemia and to examine the effects of hydroxyurea on reverse cardiac remodeling. We reviewed the records of patients with sickle cell anemia who underwent routine cardiac screening at Cohen Children's Medical Center between 2010 and 2017, followed by retrospective longitudinal analysis of echocardiograms performed on patients receiving treatment with hydroxyurea. Data on a total of 100 patients with sickle cell anemia were analyzed; 60 (60%) were being treated with hydroxyurea. Twenty-five (41.6%) of the patients on hydroxyurea had been treated for <1 year; these patients had a significantly greater prevalence of left ventricular dilation compared with those who had been on treatment for >1 year. Serial echocardiograms of patients receiving hydroxyurea were then analyzed. Left ventricular dilation and hypertrophy improved significantly with hydroxyurea treatment. In addition, the left ventricular volume and mass correlated negatively with duration of treatment with hydroxyurea. Our study provides evidence that prolonged hydroxyurea therapy may lead to reverse cardiac remodeling. Future studies should attempt to follow up this patient cohort for a longer duration.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Dhar A, Leung TM, Appiah-Kubi A, et al. Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy. Blood Adv. 2021. PMID: 34529023. doi:10.1182/bloodadvances.2021005076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。